Overview
Invasive Ductal Carcinoma (IDC) is a type of cancer that originates in the milk ducts of the breast and can spread to other parts of the body. It is the most common form of breast cancer, accounting for around 80% of all breast cancer cases, making early detection and diagnosis extremely important to ensure successful treatment. IDC is typically treated with surgery, radiation and chemotherapy, depending on the stage and type of cancer. In addition, hormone therapy or targeted therapy may be recommended depending on the patient’s individual case. With early detection, the prognosis for IDC is generally positive, although it is important to note that prognosis vary between individual cases. Knowing the signs and symptoms of IDC, such as changes in the size or shape of the breast, a visible lump in the breast, or fluid from the nipple is critical to seeking early medical help and obtaining the best possible outcome.
Research published in this journal
2 peer-reviewed articles, ranked by relevance. Each links to its DOI.
How this research is being cited
The 2 articles above have been cited 4 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
-
Iman Ehsan et al. · 2022 · Journal of Drug Delivery Science and Technology
-
2019 · Journal of Experimental and Clinical Toxicology
-
2014 · Journal of Cancer Genetics and Biomarkers
A sample of recent works citing this journal's research on Invasive Ductal Carcinoma, linking to each citing work.